BGF, Scottish National Investment Bank and Scottish Enterprise to invest £8m Elasmogen
Elasmogen – a biopharmaceutical company discovering and developing new therapeutics using its soloMERTM platform – has secured £8 million investment. The funding round was led by BGF and Scottish National Investment Bank (The Bank), with additional support from existing investor Scottish Enterprise. The multi-million-pound investment will enable Aberdeen-based Elasmogen to